Acuitas is the premier LNP (lipid nanoparticle) technology provider, enabling our partners to advance new therapeutics to address unmet clinical needs. We have developed a broad IP portfolio focussed on the use of LNP technology for nucleic acid therapeutics. This portfolio primarily encompasses novel compositions of matter but also includes novel uses of nucleic acids therapeutics.
Our mission is
· To provide our partners with the best LNP delivery technology for nucleic acid therapeutics
· To support our partners to rapidly advance new therapeutics to address unmet medical needs
· To continually innovate to maintain and strengthen our LNP technological lead
Acuitas partners locally and globally with companies, academic institutes and other organizations to improve human health.
Company Details
- Employees
- 77
- Founded
- -
- Address
- 6190 Agronomy Rd, Vancouver,british Columbia V6t,canada
- in****@****stx.com
- Industry
- Biotechnology
- Website
- acuitastx.com
- Keywords
- Officer jobs.
- HQ
- Vancouver, British Columbia
Acuitas Therapeutics Questions
Acuitas Therapeutics's website is acuitastx.com
Acuitas Therapeutics's LinkedIn profile is https://ca.linkedin.com/company/acuitastx
Acuitas Therapeutics has
77 employees.
View email and phone details for 77
employees at Acuitas Therapeutics.
Acuitas Therapeutics's industry is
Biotechnology
Acuitas Therapeutics's top competitors are
Admare Bioinnovations,
Zymeworks Inc.,
Stemcell Technologies,
Life Sciences Bc,
Aspect Biosystems,
Abcellera,
Nanovation Therapeutics™,
Notch Therapeutics,
Abdera Therapeutics,
Xenon Pharmaceuticals Inc..
Acuitas Therapeutics's support email address is info@acuitastx.com
Acuitas Therapeutics's categories are Biotechnology
Acuitas Therapeutics's founding year is 2009
